Retrospective analysis of radiotherapy plans for prostate cancer after revision of MRI targeted lesions detected by Quantib
ANNUAL MEETING OF THE ITALIAN SOCIETY OF URO-ONCOLOGY (SIURO), 2023
- Retrospective evaluation coverage of therapy plans in 5 subjects with prostate cancer who underwent hypofractionated radiotherapy.
- These preliminary results showed that Quantib can assist the identification of target lesions, and confirmed optimal radiotherapy coverage of the target volume and a subsequent biochemical response at minimal follow-up.
Learn more
Disclaimers:
DeepHealth Prostate is manufactured as Quantib Prostate by Quantib BV for DeepHealth Inc.,
DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc.,
DeepHeath Lung Tracker is manufactured as Veye Clinic by Aidence BV for DeepHealth Inc. and
DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc.
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please
contact us
